Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kusuri No Aoki HoldingsTSE:3549 -0.78%91 EV-to-EBITDA is 11.86 as of Aug. 27, 2026, which is 31% below its 10-year median of 17.14. GuruFocus rates TSE:3549 with a GF Score™ of 91/100 and a GF Value™ of 円4,322.38 (Fairly Valued). The stock has 4 warning signs investors should review. Among 518 Healthcare Providers & Services companies, Kusuri No Aoki Holdings ranks worse than 55.02% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Kusuri No Aoki Holdings's enterprise value is 円487,599 Mil.
Kusuri No Aoki Holdings's EBITDA for the trailing twelve months (TTM) ended in May. 2026 was 円41,123 Mil. Therefore, Kusuri No Aoki Holdings's EV-to-EBITDA for today is 11.86.
The historical rank and industry rank for Kusuri No Aoki Holdings's EV-to-EBITDA or its related term are showing as below:
TSE:3549'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.4 Med: 17.14 Max: 29.14
Current: 11.86
During the past 13 years, the highest EV-to-EBITDA of Kusuri No Aoki Holdings was 29.14. The lowest was 10.40. And the median was 17.14.
TSE:3549's EV-to-EBITDA is ranked worse than 55.02% of 518
companies
in the Healthcare Providers & Services industry
Industry Median: 10.545
vs TSE:3549: 11.86
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Kusuri No Aoki Holdings (TSE:3549) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Kusuri No Aoki Holdings's PE Ratio (TTM) for today is calculated as:
Kusuri No Aoki Holdings's share price for today is 円4178.00.
Kusuri No Aoki Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円176.950.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kusuri No Aoki Holdings EV-to-EBITDA Competitor Comparison
For the Pharmaceutical Retailers subindustry, Kusuri No Aoki Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kusuri No Aoki Holdings EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Kusuri No Aoki Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Kusuri No Aoki Holdings's EV-to-EBITDA falls into.
Kusuri No Aoki Holdings's current Enterprise Value is 円487,599 Mil.
Kusuri No Aoki Holdings's EBITDA for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円41,123 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kusuri No Aoki Holdings (TSE:3549) has a EV-to-EBITDA of 11.86 as of Aug. 27, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Kusuri No Aoki Holdings. This is 31% below median its historical median of 17.14. Over the past decade, Kusuri No Aoki Holdings' EV-to-EBITDA has ranged from 10.40 to 29.14. According to the industry distribution chart, Kusuri No Aoki Holdings ranks #285 out of 518 companies in the Healthcare Providers & Services industry, placing it in the top 55%.
Is Kusuri No Aoki Holdings' EV-to-EBITDA too high?
Kusuri No Aoki Holdings' current EV-to-EBITDA of 11.86 is 31% below median its 10-year median of 17.14. Over the past 10 years, this metric has ranged from a low of 10.40 to a high of 29.14. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.55. Kusuri No Aoki Holdings' value of 11.86 is 12.5% above this industry median. Based on the distribution chart, Kusuri No Aoki Holdings ranks #285 out of 518 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Kusuri No Aoki Holdings has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kusuri No Aoki Holdings' EV-to-EBITDA compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Kusuri No Aoki Holdings ranks #285 out of 518 companies for EV-to-EBITDA. This places Kusuri No Aoki Holdings in the lower half of its industry. The industry median EV-to-EBITDA is 10.55. Kusuri No Aoki Holdings' value of 11.86 is 12.5% above this benchmark. Historically, Kusuri No Aoki Holdings' own EV-to-EBITDA has ranged from 10.40 to 29.14 over the past decade. While the company's 10-year median is 17.14 vs. the industry median of 10.55, Kusuri No Aoki Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.55, based on 518 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kusuri No Aoki Holdings's current EV-to-EBITDA of 11.86 is 12.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Kusuri No Aoki Holdings. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kusuri No Aoki Holdings's current EV-to-EBITDA is 11.86, which is 31% below median its own 10-year median of 17.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kusuri No Aoki Holdings stock overvalued right now?
Based on GuruFocus' analysis, Kusuri No Aoki Holdings (TSE:3549) is currently considered Fairly Valued. The stock's GF Value™ is 円4,322.38, compared to a current price of 円4,178.00 — trading 3.3% below its estimated fair value. The current EV-to-EBITDA is 11.86, which is 31% below median its 10-year median of 17.14 and 12.5% above the Healthcare Providers & Services industry median of 10.55. Kusuri No Aoki Holdings' overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Kusuri No Aoki Holdings (TSE:3549), the current EV-to-EBITDA is 11.86 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kusuri No Aoki Holdings (TSE:3549) Overvalued in 2026?
Based on GuruFocus' analysis, Kusuri No Aoki Holdings stock appears to be undervalued.
The current stock price of 円4,178.00 is trading 3.3% below its estimated GF Value™ of 円4,322.38.
GuruFocus considers Kusuri No Aoki Holdings to be Fairly Valued.
Key valuation signals for TSE:3549:
EV-to-EBITDA: 11.86 (31% below median its 10-year median of 17.14)
GF Value™: 円4,322.38 vs. price of 円4,178.00 (3.3% below fair value)
Industry Position: 12.5% above the Healthcare Providers & Services median (#285 of 518)
No single metric tells the full story. See the TSE:3549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kusuri No Aoki Holdings is a pharmaceutical retail chain that sells health, beauty, and cleaning supplies. The company operates stores that focus primarily on residential areas in Japan. Kusuri's business includes pharmaceutical drugs, and the company also operates a bone-marrow bank. The company breaks out its sales into four different product lines, including health, beauty, life, and dispensing. The vast majority of the company's revenue is derived from its life product category, followed by beauty products. Most of Kusuri's revenue is derived from the Hokuriku region.
91GF Score
Get the complete analysis for TSE:3549
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3549 has been successfully added to your 
